Prostate Artery Embolization for Benign Prostatic Hyperplasia
Customize your policy alerts
Sign up for Blue Cross Blue Shield - Massachusetts Policy 235 alerts
Get alerted when Policy 235 changes without checking for updates manually.
Monitor payer policy activity
Coverage and prior authorization for prostate artery embolization used to treat benign prostatic hyperplasia for Commercial and Medicare Advantage members; the service is investigational and not covered.
No material clinical or coverage changes in this revision.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.